Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Plos One
|
August 30, 2018
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India
Sivasankaran Munusamy Ponnan, Soumya Swaminathan, Kannan Tiruvengadam, et al.
Plos One
|
April 21, 2025
Acceptability of broadly neutralizing antibodies (bNAbs) for HIV prevention among vulnerable populations in India: Findings from a qualitative study
Joyeeta Mukherjee, Saif Ul Hadi, Venkatesan Chakrapani, et al.
Pathogens and Disease
|
September 11, 2019
Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors
Chinnambedu Ravichandran Swathirajan, Pannerselvam Nandagopal, Ramachandran Vignesh, et al.
Plos One
|
March 29, 2019
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India
Sivasankaran Munusamy Ponnan, Sathyamurthy Pattabiram, Kannan Thiruvengadam, et al.
Plos One
|
February 26, 2020
Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India
Sivasankaran Munusamy Ponnan, Peter Hayes, Natalia Fernandez, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Plos One
|
August 30, 2018
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India
Sivasankaran Munusamy Ponnan, Soumya Swaminathan, Kannan Tiruvengadam, et al.
Plos One
|
April 21, 2025
Acceptability of broadly neutralizing antibodies (bNAbs) for HIV prevention among vulnerable populations in India: Findings from a qualitative study
Joyeeta Mukherjee, Saif Ul Hadi, Venkatesan Chakrapani, et al.
Pathogens and Disease
|
September 11, 2019
Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors
Chinnambedu Ravichandran Swathirajan, Pannerselvam Nandagopal, Ramachandran Vignesh, et al.
Plos One
|
March 29, 2019
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India
Sivasankaran Munusamy Ponnan, Sathyamurthy Pattabiram, Kannan Thiruvengadam, et al.
Plos One
|
February 26, 2020
Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India
Sivasankaran Munusamy Ponnan, Peter Hayes, Natalia Fernandez, et al.
Page
of 3